Introduction
NADH dehydrogenase, or mitochondrial Complex-1, is a part of the electron transport chain and is a multi-protein enzyme thought to be comprised of about 45 subunits (Koopman et al., 2010) . It is also one of the largest and most intricate protein complexes of the eukaryotic cell (Janssen et al., 2006) . As the first enzyme in oxidative phosphorylation, Complex-1 catalyzes the abstraction of two electrons from NADH and transfers them to ubiquinone. At the same time, it pumps four protons across the mitochondrial inner membrane, contributing to the proton gradient used for ATP production (Mitchell, 1961) . The L-shaped Complex-1 consists of a membrane bound portion (anchored to the inner mitochondrial membrane) and a large matrix-facing protrusion containing the NADH binding site (Sazanov et al., 2000) . The assembly of Complex-1 is still poorly understood, but is thought to follow a stepwise process in which the subunits are first assembled in multiple, smaller independent sub-complexes. The membrane-bound sub-complexes consist predominantly of mitochondrially encoded subunits, whereas the matrix-facing sub-complexes are composed of largely nuclear encoded subunits (Ugalde et al., 2004) . To date, an array of 7 assembly factors have been identified which are required to form mature Complex-1, which has a total molecular mass of~1 MDa (Koopman et al., 2010) .
Loss-of-function mutations within genes encoding mitochondrial Complex-1 subunits are among the most common cause of respiratory chain disorders, and can result in a wide variety of clinical phenotypes spanning from early onset fatal phenotypes to adult onset exercise intolerance (Loeffen et al., 2000) . The tissues affected in these disorders can manifest a similarly diverse set of pathologies, but frequently involve neurodegeneration, such as in Leigh's syndrome, Leber's hereditary optic neuropathy, MELAS, or MERFF (McFarland et al., 2007) . In addition to these primary genetic defects in Complex-1 associated genes, deficits in Complex-1 activity have also been implicated in neurodegenerative diseases such as idiopathic Parkinson's disease, Alzheimer's disease, Huntington's disease and Amyotrophic lateral sclerosis (Schon and Przedborski, 2011) .
It has become clear in recent years that Complex-1 deficiency disorders do not arise solely from mutations in the structural or enzymatic subunits, but rather are increasingly linked to mutations in its assembly factors, as well. Ndufaf2 is a Complex-1 assembly factor and five patients with homozygous deletion of Ndufaf2 have been described thus far (Herzer et al., 2010) . They developed severe encephalopathy, mostly involving the midbrain and brainstem, leading to premature death during childhood. A heterozygous Ndufaf2 deletion has been observed in a 
